Natera, Inc. (NTRA) income statement
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30140% above fair value
$289.50+2.03 (+0.71%)
Close on Nov 18, 2026Market cap $41.73BP/E –Yield –
Natera, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -10.7%
- Net margin
- -7.1%
- Return on equity, FY2025
- -14.3%
Financial strength
- Current ratio
- 3.00
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 197.3%
Valuation
- P/E ratio
- –
- Price to sales
- 15.42
- Price to book
- 22.91
- Dividend yield
- –
See a number that looks wrong?